Insulet Corporation (PODD) Misses Q4 EPS by 4c; Guides FY12 Revs

Insulet Corporation (NASDAQ: PODD) reported Q4 EPS of ($0.30), $0.04 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $47.2 million versus the consensus estimate of $47.44 million.

Sees FY2012 revenue of $210-$225 million, versus the consensus of $218.4 million.

For earnings history and earnings-related data on Insulet Corporation (PODD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• Diana Shipping drops bid for Genco after price demands spike to $36.91
• Movano (MOVE) Misses Q2 EPS by 195c